Brevard Achievement Center (BAC)recently a series of personnel moves that the organization says reflects its continued growth ...

ADT returns as the presenting partner of FanFest, which will take place at loanDepot park on Saturday, February 7, from 4-8 p ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

This is part of our annual series of places where Black History happened It must be nice to live in a world where it’s easy ...

Tolmar, Inc. today announced the launch of Care Partner Corner ( a comprehensive digital resource created specifically to support and empower care partners of prostate cancer patients. This free, easy ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Major stock indexes closed sharply lower and bitcoin plunged to near $62,000 Thursday amid broad risk-off sentiment, as ...

The Sector Specialised Operations Patrollers (SSOP) held their first community engagement for 2026, which was well-attended ...

Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...